In the global pharmaceutical arena, India has long been known as the “Pharmacy of the World.” With its robust formulation industry and a large volume of generic drug exports, India has been a trusted source of affordable medicines for many countries. However, underneath this strength lies a critical vulnerability—heavy dependence on imports for Active Pharmaceutical Ingredients (APIs), the building blocks of most drugs.